Abstract:
Techniques are provided for tracking and analyzing defect density by source file or module. Defect density is the number of distinct defects which required changes to be made (to fix the defect) to a particular file or module in a given period of time. This metric is very useful for identifying the most critical areas of weakness of the system and hence the areas where additional investment/action may be taken. For example, this metric can be used to prioritize the area in which unit tests should be written, for which additional automated system tests should be written or which a project should be undertaken to re-write the error prone file or module to improve its quality and maintainability.
Abstract:
Techniques are provided for capturing the ID of a work item, and the corresponding effort level information, as a part of the actual check-in process of the artifacts into the underlying change management system. This effort information can then be propagated to an external system for subsequent reporting and analysis. In one embodiment, tasks (or similar items such as issues or bugs) are entered into a common task or issue tracking system. As part of this process each task is assigned a unique identifier. A “call-out” is added to the source control management system which captures the effort level and task ID associated with the proposed change. The data entered is validated to ensure that the task ID is valid and that the effort entered is within a valid range. If the data entered is valid, the change to the underlying artifact is allowed to proceed and the effort and task information is stored for later analysis. If the data is not valid, the proposed change is rejected and an appropriate error message is returned to the user.
Abstract:
A source sampling rate is associated with first or second groups of sampling rates. A playback rate is determined by: (a) selecting the source sampling rate if the source sampling rate is supported by a playback environment; (b) otherwise if there is a highest first rate from the first or second groups of playback sampling rates which is supported by the playback environment and is lower than the source sampling rate, selecting the first rate; (c) otherwise if there is a slowest second rate from the group that the source sampling rate is associated with that is supported by the playback environment and is higher than the source sampling rate, selecting the second rate; (d) otherwise selecting the slowest sampling rate supported by the playback environment from the group that the source sampling rate is not associated with as the playback rate.
Abstract:
In one embodiment, a client device may send one or more sub-session requests to one or more corresponding session controllers through a computer network to obtain one or more corresponding sub-session tokens that indicate in which sub-sessions of an online collaborative computing session the client device is permitted to participate. The client device may then receive particular sub-session tokens (e.g., based on certain permissions), which may then be sent to a collaboration server to establish one or more permitted sub-sessions of the online collaborative computing session with the client device as indicated by the received sub-session tokens.
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using naphthyridine derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of naphthyridine derivatives.
Abstract:
The invention relates to micropumps for infusing fluids. More specifically, the present disclosure describes and illustrates a micropump design that may be useful for infusing insulin into a diabetic patient. The disclosed design employs a pump chamber that has a diaphragm and a plurality of check valves that are configured to avoid leakage from the reservoir through the pump engine and into an infusion device and, also, to ensure the complete, accurate evacuation of the pump chamber.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.
Abstract:
In one embodiment, the systems and methods detect audio content shared during a collaboration session; detect a participant associated with originating the audio content; store or record audio content; and automatically associate the audio content with the participant.
Abstract:
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and chimeric antibodies, methods of producing the antibody, methods of use of the anti-TNF antibody, or fragment, region or derivative thereof, in immunoassays and immunotherapeutic approaches are provided.